C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Invests $2.28 Million in Henry Schein, Inc. (NASDAQ:HSIC)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, Holdings Channel.com reports. The firm acquired 32,968 shares of the company’s stock, valued at approximately $2,281,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Clarkston Capital Partners LLC grew its position in shares of Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after buying an additional 71,560 shares during the period. Nuance Investments LLC boosted its stake in Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after acquiring an additional 414,748 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in Henry Schein during the third quarter valued at approximately $515,000. Olstein Capital Management L.P. increased its stake in Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after purchasing an additional 16,000 shares in the last quarter. Finally, Thrivent Financial for Lutherans raised its holdings in Henry Schein by 1,848.9% in the third quarter. Thrivent Financial for Lutherans now owns 105,415 shares of the company’s stock worth $7,685,000 after purchasing an additional 100,006 shares during the period. 96.62% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Trading Down 0.4 %

Shares of NASDAQ:HSIC opened at $77.20 on Thursday. The stock has a market capitalization of $9.63 billion, a PE ratio of 31.77, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91. The company’s 50-day moving average price is $73.85 and its two-hundred day moving average price is $71.93. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on HSIC. Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Finally, Barrington Research boosted their price objective on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Thursday, January 30th. Seven analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and a consensus price target of $80.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.